One thing I’ve noticed is that the right developmental life cycle often depends less on the industry and more on how mature the requirements and risk profile are at a given stage. In medical devices, ...

One thing I’d add is that a strong DHF isn’t just about having all the right documents, it's also about showing clear traceability and change control throughout the project. Design changes can't be av...

One additional factor that influences a medical device’s product life cycle is how well design transfer and manufacturing readiness are handled early on. Even if a device performs well during developm...

I think the threshold for moving from repeated verification iterations to a formal scope change should be based less on the number of failures and more on whether the proposed fix introduces new regul...

One angle I haven’t seen discussed yet is how much the intended use and claims of a device can influence whether a company ends up on the PMA or 510(k) pathway, sometimes more than the technology itse...

I think one of the most effective ways for project managers to work within the FDA’s constraints is by involving regulatory considerations early on, instead of treating them as something to deal with ...

A lot of great points here focus on communication, prioritization, and technical awareness, but one skill I think ties all of those together is decision-making under uncertainty. In biomedical project...

One thing I haven’t seen discussed yet is how the best background for a medical device PM might actually depend on what stage of the product lifecycle the project is in. Early on, when concepts are st...

Another angle is that ongoing conflict can sometimes point to a process issue rather than a people issue. If a project manager and a highly skilled team member keep clashing, it may mean there isn’t a...

One issue I see with depending too much on FMEAs is that they are predicated on the idea that failures occur one component at a time in predictable ways. However, contemporary medical devices do not m...

One thing that often gets overlooked is that risk isn’t just tied to the device design but it’s tied to the patient using it. Two people with the same pacemaker can have completely different reactions...

Sometimes a mitigation doesn’t make the product safer overall, it just transfers the risk to a different user group, workflow, or failure mode. For ex., adding too many alarms on a medical device can ...

Everyone’s shared great technical solutions, but another issue behind documentation fatigue is how people interact with the process, not just the tools themselves. When updates feel like busywork inst...

Everyone’s made great points about prediction limits and company oversight. Another major gap is that verification and validation don’t really reflect real-life patient diversity. The DePuy implants m...

While many have raised valid points about adaptive algorithms and overconfidence in structured systems, I think a modern “Therac moment” could result less from technical gaps and more from ethical and...